Kyung Hyun Moon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kyung Hyun Moon has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Sungchan Park
Basic-Clinic Convergence Research Institute, University of Ulsan, Ulsan, Korea
10 shared publications - Taekmin Kwon
Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
9 shared publications - Seong Cheol Kim
Basic-Clinic Convergence Research Institute, University of Ulsan, Ulsan, Korea
8 shared publications - Ji Hyung Yoon
Basic-Clinic Convergence Research Institute, University of Ulsan, Ulsan, Korea
4 shared publications - Sang Hyeon Cheon
Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
4 shared publications - Sejun Park
Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
4 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Dipeptidyl Peptidase-4 Inhibitor Enhances the Efficacy of Docetaxel via Adenosine Triphosphate Depletion and Modulation of Mitochondrial Fusion-Fission in Castration-Resistant Prostate Cancer
Lee WH, et al. World J Mens Health. 2026 ;44:e85. https://doi.org/10.5534/wjmh.260048
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Open AccessDipeptidyl Peptidase-4 Inhibitor Enhances the Efficacy of Docetaxel via Adenosine Triphosphate Depletion and Modulation of Mitochondrial Fusion-Fission in Castration-Resistant Prostate Cancer
Lee WH, et al. World J Mens Health. 2026 ;44:e85. https://doi.org/10.5534/wjmh.260048
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Age-Related Testosterone Decline and Metabolic Determinants in 27,687 Korean Men Aged ≥40 Years: A Nationwide Population-Based Study
Kim TH, et al. World J Mens Health. 2026 ;44:e43. https://doi.org/10.5534/wjmh.250369
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Open AccessAge-Related Testosterone Decline and Metabolic Determinants in 27,687 Korean Men Aged ≥40 Years: A Nationwide Population-Based Study
Kim TH, et al. World J Mens Health. 2026 ;44:e43. https://doi.org/10.5534/wjmh.250369
- Open Access
- 9 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (19) , e42222
Is it effective to do mathematical analysis for the etiology of nocturia using the nocturia indices derived from the frequency volume chart?: A retrospective observational study
This study aims to determine the problems involved in using a mathematical calculation to analyze the pathophysiology of nocturia using a frequency volume chart (FVC). In this retrospective study, we reviewed 253 patients who completed the FVC during ≥ 3 days for nocturia from January 2017 to February 2019. The etiology of nocturia was defined as a combination of 4 pathophysiologies, including nocturnal polyuria (NP), decreased bladder capacity (dBC), decreased nocturnal bladder capacity, and global polyuria. To analyze the differences according to diagnostic criteria for NP and dBC, 2 definitions were classified. Definition 1: NP is NP index (NPi) > 0.35 and dBC as maximal voided volume (MVV) < 325 mL. Definition 2: NP is NPi = 0.20 to 0.33 depending on age and dBC as MVV < 200 mL. The MVV in the FVC for ≥3 days was significantly higher than that for 1 day (330 mL vs 400 mL, P < .001). During the entire FVC period, all pathophysiology remained unchanged in only 16.6% of cases (inter-day variation). Of 323 days in which nocturia occurred ≥ 2 per night, 118 days (36.5%) full bladder voiding of nocturia was not the same for each day (inter-nocturia variation). According to definitions 1 and 2, the serial changes of NP and dBC showed different patterns. The mathematical calculation used in analyzing the pathophysiology of nocturia using an FVC has problems such as differences according to the duration of FVC and inability to express inter-day and inter-nocturia variations. Therefore, this mathematical calculation is not helpful when determining the treatment modality for nocturia.
- 9 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (19) , e42222
Open AccessIs it effective to do mathematical analysis for the etiology of nocturia using the nocturia indices derived from the frequency volume chart?: A retrospective observational study
This study aims to determine the problems involved in using a mathematical calculation to analyze the pathophysiology of nocturia using a frequency volume chart (FVC). In this retrospective study, we reviewed 253 patients who completed the FVC during ≥ 3 days for nocturia from January 2017 to February 2019. The etiology of nocturia was defined as a combination of 4 pathophysiologies, including nocturnal polyuria (NP), decreased bladder capacity (dBC), decreased nocturnal bladder capacity, and global polyuria. To analyze the differences according to diagnostic criteria for NP and dBC, 2 definitions were classified. Definition 1: NP is NP index (NPi) > 0.35 and dBC as maximal voided volume (MVV) < 325 mL. Definition 2: NP is NPi = 0.20 to 0.33 depending on age and dBC as MVV < 200 mL. The MVV in the FVC for ≥3 days was significantly higher than that for 1 day (330 mL vs 400 mL, P < .001). During the entire FVC period, all pathophysiology remained unchanged in only 16.6% of cases (inter-day variation). Of 323 days in which nocturia occurred ≥ 2 per night, 118 days (36.5%) full bladder voiding of nocturia was not the same for each day (inter-nocturia variation). According to definitions 1 and 2, the serial changes of NP and dBC showed different patterns. The mathematical calculation used in analyzing the pathophysiology of nocturia using an FVC has problems such as differences according to the duration of FVC and inability to express inter-day and inter-nocturia variations. Therefore, this mathematical calculation is not helpful when determining the treatment modality for nocturia.
- Open Access
- 1 January 2024
- Published by XMLink in Investigative and Clinical Urology
- Vol. 65 (2) , 124-131
Analysis of trend in the role of national and regional hubs in prostatectomy after prostate cancer diagnosis in the past 5 years: A nationwide population-based study
Kim SC, et al. Investig Clin Urol. 2024 Mar;65(2):124-131. https://doi.org/10.4111/icu.20230333
- 1 January 2024
- Published by XMLink in Investigative and Clinical Urology
- Vol. 65 (2) , 124-131
Open AccessAnalysis of trend in the role of national and regional hubs in prostatectomy after prostate cancer diagnosis in the past 5 years: A nationwide population-based study
Kim SC, et al. Investig Clin Urol. 2024 Mar;65(2):124-131. https://doi.org/10.4111/icu.20230333
- Open Access
- 1 January 2023
- Published by XMLink in The World Journal of Men's Health
- Vol. 41 (3) , 649-658
Docetaxel Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Prostate Cancer Cells via Epigenetic Gene Regulation by Enhancer of Zeste Homolog 2
Lee WH, et al. World J Mens Health. 2023 Jan;41:e2. https://doi.org/10.5534/wjmh.220073
- 1 January 2023
- Published by XMLink in The World Journal of Men's Health
- Vol. 41 (3) , 649-658
Open AccessDocetaxel Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Prostate Cancer Cells via Epigenetic Gene Regulation by Enhancer of Zeste Homolog 2
Lee WH, et al. World J Mens Health. 2023 Jan;41:e2. https://doi.org/10.5534/wjmh.220073
- Open Access
- 15 November 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (47) , e333
Epidemiology and Management Trend of Renal Trauma: Results of a Nationwide Population-Based Study
Tae BS, et al. J Korean Med Sci. 2022 Nov;37(47):e333. https://doi.org/10.3346/jkms.2022.37.e333
- 15 November 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (47) , e333
Open AccessEpidemiology and Management Trend of Renal Trauma: Results of a Nationwide Population-Based Study
Tae BS, et al. J Korean Med Sci. 2022 Nov;37(47):e333. https://doi.org/10.3346/jkms.2022.37.e333
- Open Access
- 28 October 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (43) , e31295
Analysis of changes in the pathophysiology of nocturia according to the number of nocturia episode, age, and gender using frequency volume charts: A retrospective observational study
Purpose: To evaluate the pathophysiology of nocturia based on the frequency volume chart, and determine the risk factors for nocturia occurring ≥2 times per night. Materials and methods: In this retrospective study, we reviewed 311 patients with complaints of nocturia from January 2017 to February 2019 at our institution. Nocturnal polyuria (NP) and global polyuria (GP) were defined as NP index >0.35 regardless of age and 24 h urine volume >2.5 L/day, respectively. Decreased bladder capacity (dBC) was when the maximal voided volume was 0. Results: In total, 273 patients were included in the primary analyses. Of 802 days from 273 frequency volume charts, the median number of nocturia was 1 episode per day. Further, NP (odds ratios [OR] 7.01), GP (OR 4.25), dBC (OR 3.00), dNBC (OR 10.12), and age (OR 1.04) had the association with nocturia ≥2 times per night. There was a significant stepwise increase in NP, dNBC, dBC, and GP with the number of nocturia episodes. As patient age increased, the likelihood of NP (P < 0.001) and dBC (P < 0.001) being the cause for nocturia tended to increase, but that of dNBC (P = 0.022) and nocturia without cause (P = 0.007) tended to decrease. Moreover, dBC was more likely to cause nocturia in female patients than in male patients (P < 0.001). Conclusion: NP, dBC, dNBC, and GP are important factors involved in the pathophysiology of nocturia occurring ≥2 times per night.
- 28 October 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (43) , e31295
Open AccessAnalysis of changes in the pathophysiology of nocturia according to the number of nocturia episode, age, and gender using frequency volume charts: A retrospective observational study
Purpose: To evaluate the pathophysiology of nocturia based on the frequency volume chart, and determine the risk factors for nocturia occurring ≥2 times per night. Materials and methods: In this retrospective study, we reviewed 311 patients with complaints of nocturia from January 2017 to February 2019 at our institution. Nocturnal polyuria (NP) and global polyuria (GP) were defined as NP index >0.35 regardless of age and 24 h urine volume >2.5 L/day, respectively. Decreased bladder capacity (dBC) was when the maximal voided volume was 0. Results: In total, 273 patients were included in the primary analyses. Of 802 days from 273 frequency volume charts, the median number of nocturia was 1 episode per day. Further, NP (odds ratios [OR] 7.01), GP (OR 4.25), dBC (OR 3.00), dNBC (OR 10.12), and age (OR 1.04) had the association with nocturia ≥2 times per night. There was a significant stepwise increase in NP, dNBC, dBC, and GP with the number of nocturia episodes. As patient age increased, the likelihood of NP (P < 0.001) and dBC (P < 0.001) being the cause for nocturia tended to increase, but that of dNBC (P = 0.022) and nocturia without cause (P = 0.007) tended to decrease. Moreover, dBC was more likely to cause nocturia in female patients than in male patients (P < 0.001). Conclusion: NP, dBC, dNBC, and GP are important factors involved in the pathophysiology of nocturia occurring ≥2 times per night.
- Open Access
- 28 December 2021
- Published by XMLink in The World Journal of Men's Health
- Vol. 40 (4) , 653-662
Therapeutic Effect of Human Mesenchymal Stem Cell-Conditioned Medium on Erectile Dysfunction
Kim SG, et al. World J Mens Health. 2022 Oct;40(4):653-662. https://doi.org/10.5534/wjmh.210121
- 28 December 2021
- Published by XMLink in The World Journal of Men's Health
- Vol. 40 (4) , 653-662
Open AccessTherapeutic Effect of Human Mesenchymal Stem Cell-Conditioned Medium on Erectile Dysfunction
Kim SG, et al. World J Mens Health. 2022 Oct;40(4):653-662. https://doi.org/10.5534/wjmh.210121
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S677-S678
Comparison of the surgical outcomes and couples’ satisfaction with the type of penile prosthesis; Malleable versus Inflatable penile prosthesis: From 157 patients with erectile dysfunction who underwent penile prosthesis implantation in single center
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S677-S678
Comparison of the surgical outcomes and couples’ satisfaction with the type of penile prosthesis; Malleable versus Inflatable penile prosthesis: From 157 patients with erectile dysfunction who underwent penile prosthesis implantation in single center
- 27 February 2021
- Published by Wiley in Pediatrics International
- Vol. 63 (12) , 1490-1494
Reduced bladder capacity without daytime voiding symptoms with nocturnal enuresis
Background: This study aimed to evaluate the prevalence of monosymotomatic nocturnal enuresis (MSNE) with reduced bladder capacity in children with primary nocturnal enuresis (NE) and to suggest treatment outcomes.Methods: This study retrospectively evaluated 54 children (30 males, 24 females; median age: 8; range: 5–14) who were newly diagnosed with primary NE from November 2017 to October 2019. Reduced bladder capacity in MSNE was defined when a patient’s maximal voided volume (MVV) from his or her voiding diary was 75% or less than estimated functional bladder capacity ([age + 1] x 30 mL) for his or her age and there were no daytime lower urinary tract symptoms (LUTS) as assessed using history taking and questionnaires.Results: Nineteen (35.2%) of 54 children with newly diagnosed primary NE did not report daytime LUTS. Fifteen children (27.8%) had a reduced bladder capacity and were prescribed anticholinergic or beta‐3 agonist. After three months of medication, MVV significantly increased from 117.5 mL to 183.3 mL (P = 0.010), but frequency showed no significant change from 5.7 to 4.9 times a day. Improvement in enuresis occurred completely and partially in 41.7% and 25% of participants, respectively.Conclusions: The prevalence of reduced bladder capacity without daytime voiding symptoms was relatively high as 27.8% in children newly diagnosed with primary NE. In primary MSNE, reduced bladder capacity should be investigated using a frequency‐volume chart in addition to thorough history taking or questionnaires. Anticholinergics or beta‐3 agonists for MSNE with reduced bladder capacity are effective at increasing the bladder capacity of these patients.
- 27 February 2021
- Published by Wiley in Pediatrics International
- Vol. 63 (12) , 1490-1494
Reduced bladder capacity without daytime voiding symptoms with nocturnal enuresis
Background: This study aimed to evaluate the prevalence of monosymotomatic nocturnal enuresis (MSNE) with reduced bladder capacity in children with primary nocturnal enuresis (NE) and to suggest treatment outcomes.Methods: This study retrospectively evaluated 54 children (30 males, 24 females; median age: 8; range: 5–14) who were newly diagnosed with primary NE from November 2017 to October 2019. Reduced bladder capacity in MSNE was defined when a patient’s maximal voided volume (MVV) from his or her voiding diary was 75% or less than estimated functional bladder capacity ([age + 1] x 30 mL) for his or her age and there were no daytime lower urinary tract symptoms (LUTS) as assessed using history taking and questionnaires.Results: Nineteen (35.2%) of 54 children with newly diagnosed primary NE did not report daytime LUTS. Fifteen children (27.8%) had a reduced bladder capacity and were prescribed anticholinergic or beta‐3 agonist. After three months of medication, MVV significantly increased from 117.5 mL to 183.3 mL (P = 0.010), but frequency showed no significant change from 5.7 to 4.9 times a day. Improvement in enuresis occurred completely and partially in 41.7% and 25% of participants, respectively.Conclusions: The prevalence of reduced bladder capacity without daytime voiding symptoms was relatively high as 27.8% in children newly diagnosed with primary NE. In primary MSNE, reduced bladder capacity should be investigated using a frequency‐volume chart in addition to thorough history taking or questionnaires. Anticholinergics or beta‐3 agonists for MSNE with reduced bladder capacity are effective at increasing the bladder capacity of these patients.